跳至主要内容
临床试验/IRCT20170501033750N2
IRCT20170501033750N2已完成3 期

Comparison of the effect of ranitidine syrup with Quince syrup in pediatric gastroesophageal reflux aged 12 to 48 months

Babol University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1 year 至 4 years(—)
性别
All

入选标准

  • Patients in the age group of 12 to 48 months.
  • People with at least 2 times a week with common symptoms of reflux disease (heartburn, regurgitation, vomiting, epigastric pain and appropriate weight loss for at least a month
  • Those who are newly diagnosed or who have been suffering from reflux, have not taken any medications for at least one month and will want to start their treatment again

排除标准

  • Patients with severe reflux disease (severe onset: symptoms of severe esophagitis, vomiting, life-threatening symptoms such as apnea, pneumonia, esophageal stricture and systemic diseases) due to the need for treatments Another intervention, including surgery or other medications, is withdrawn from the project because of ethical considerations (non-deprivation of the patient and non-risk for the volunteers)
  • Children with a disease (neurological, cardiac, pulmonary, liver and kidney) or mental retardation
  • People who have used other herbal remedies during this period
  • People who need to use chemical drugs during the plan due to the specific disease
  • People with a history of allergy to herbal medicines

研究者

相似试验